Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells
- PMID: 15963923
- DOI: 10.1016/j.ymthe.2005.02.024
Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells
Abstract
Two HIV-1-infected children on antiretroviral therapy were enrolled into a clinical study of retroviral-mediated transfer of a gene that inhibits replication of HIV-1, targeting bone marrow CD34+ hematopoietic stem/progenitor cells. Two retroviral vectors were used, one encoding a "humanized" dominant-negative REV protein (huM10) that is a potent inhibitor of HIV-1 replication and one encoding a nontranslated marker gene (FX) to serve as an internal control for the level of gene marking. Peripheral blood mononuclear cells (PBMC) containing the huM10 gene or FX gene were detected by quantitative PCR at frequencies of approximately 1/10,000 in both subjects for the first 1-3 months following re-infusion of the gene-transduced bone marrow, but then were at or below the limits of detection (<1/1,000,000) at most times over 2 years. In one patient, a reappearance of PBMC containing the huM10 gene, but not the FX gene, occurred concomitant with a rise in the HIV-1 viral load during a period of nonadherence to the antiretroviral regimen. Unique clones of gene-marked PBMC were detected by LAM-PCR during the time of elevated HIV-1 levels. These findings indicate that there was a selective survival advantage for PBMC containing the huM10 gene during the time of increased HIV-1 load.
Similar articles
-
Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.Mol Ther. 2005 Dec;12(6):1157-67. doi: 10.1016/j.ymthe.2005.07.698. Epub 2005 Sep 15. Mol Ther. 2005. PMID: 16168713
-
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients.J Gene Med. 2005 May;7(5):552-64. doi: 10.1002/jgm.705. J Gene Med. 2005. PMID: 15655805 Clinical Trial.
-
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication.AIDS. 2006 Aug 22;20(13):1713-20. doi: 10.1097/01.aids.0000242817.88086.8c. AIDS. 2006. PMID: 16931935
-
Hematopoietic stem cell-based gene therapy against HIV infection: promises and caveats.AIDS Rev. 2005 Jan-Mar;7(1):44-55. AIDS Rev. 2005. PMID: 15875660 Review.
-
Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.Clin Infect Dis. 2007 Jun 15;44(12):1602-10. doi: 10.1086/518167. Epub 2007 May 7. Clin Infect Dis. 2007. PMID: 17516404 Review.
Cited by
-
Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.J Virol. 2006 Feb;80(4):1863-73. doi: 10.1128/JVI.80.4.1863-1873.2006. J Virol. 2006. PMID: 16439542 Free PMC article.
-
Strong In Vivo Inhibition of HIV-1 Replication by Nullbasic, a Tat Mutant.mBio. 2019 Aug 27;10(4):e01769-19. doi: 10.1128/mBio.01769-19. mBio. 2019. PMID: 31455650 Free PMC article.
-
Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.Mol Ther. 2011 Mar;19(3):584-93. doi: 10.1038/mt.2010.269. Epub 2010 Nov 30. Mol Ther. 2011. PMID: 21119622 Free PMC article.
-
Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.Gene Ther. 2016 Feb;23(2):144-50. doi: 10.1038/gt.2015.101. Epub 2015 Oct 21. Gene Ther. 2016. PMID: 26488891
-
Stem cell gene therapy for HIV: strategies to inhibit viral entry and replication.Curr HIV/AIDS Rep. 2015 Mar;12(1):79-87. doi: 10.1007/s11904-014-0242-8. Curr HIV/AIDS Rep. 2015. PMID: 25578054 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical